1. Duplaquet, Leslie, So, Kevin, Ying, Alexander W, Kadoch, Cigall, Oser, Matthew G. 2024. Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. In Cancer cell, 42, 1352-1369.e13. doi:10.1016/j.ccell.2024.06.012. https://pubmed.ncbi.nlm.nih.gov/39029464/
2. Gay, Carl M, Stewart, C Allison, Park, Elizabeth M, Heymach, John V, Byers, Lauren Averett. 2021. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. In Cancer cell, 39, 346-360.e7. doi:10.1016/j.ccell.2020.12.014. https://pubmed.ncbi.nlm.nih.gov/33482121/
3. Wu, Xiaoli S, He, Xue-Yan, Ipsaro, Jonathan J, Joshua-Tor, Leemor, Vakoc, Christopher R. 2022. OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage. In Nature, 607, 169-175. doi:10.1038/s41586-022-04842-7. https://pubmed.ncbi.nlm.nih.gov/35576971/